Abstract:Intermittent locking of central venous catheters (CVCs) is undertaken to help maintain their patency and performance. There are systematic variations in care: some practitioners use heparin (at different concentrations), whilst others use 0.9% sodium chloride (normal saline). This review looks at the effectiveness and safety of intermittent locking with heparin compared to normal saline, to see if the evidence establishes whether one is better than the other. This is an update of an earlier Cochrane Review. To evaluate the benefits and harms of intermittent locking of CVCs with heparin versus normal saline in adults to prevent occlusion. We used standard, extensive Cochrane search methods. The latest search date was 20 October 2021. We included randomised controlled trials in adults ≥ 18 years of age with a CVC that compared intermittent locking with heparin at any concentration versus normal saline. We excluded studies on infants and children from this review. We used standard Cochrane methods. Our primary outcomes were occlusion of CVCs and duration of catheter patency. Our secondary outcomes were CVC‐related bloodstream infections and CVC‐related colonisation, mortality, haemorrhage, heparin‐induced thrombocytopaenia, CVC‐related thrombosis, number of additional CVC insertions, abnormality of coagulation profile and allergic reactions to heparin. We used GRADE to assess the certainty of evidence for each outcome. We identified one new RCT with 30 participants for this update. We included a total of 12 RCTs with 2422 participants. Data for meta‐analysis were available from all RCTs. We noted differences in methods used by the included studies and variation in heparin concentrations (10 to 5000 IU/mL), time to follow‐up (1 to 251.8 days), and the unit of analysis used (participant, catheter, line access). Five studies included ICU (intensive care unit) patients, two studies included oncology patients, and the remaining studies included miscellaneous patients (chronic kidney disease, haemodialysis, home care patients, etc.). Primary outcomes Overall, combined results may show fewer occlusions with heparin compared to normal saline but this is uncertain (risk ratio (RR) 0.70, 95% confidence interval (CI) 0.51 to 0.95; 10 studies; 1672 participants; low‐certainty evidence). We pooled studies that used participant or catheter as the unit of analysis. We carried out subgroup analysis by unit of analysis. No clear differences were detected after testing for subgroup differences (P = 0.23). We found no clear evidence of a difference in the duration of catheter patency with heparin compared to normal saline (mean difference (MD) 0.44 days, 95% CI ‐0.10 to 0.99; 6 studies; 1788 participants; low‐certainty evidence). Secondary outcomes We found no clear evidence of a difference in the following outcomes: CVC‐related bloodstream infections (RR 0.66, 95% CI 0.08 to 5.80; 3 studies; 1127 participants; very low‐certainty evidence); mortality (RR 0.76, 95% CI 0.44 to 1.31; 3 studies; 1100 participants; very low‐certainty evidence); haemorrhage (RR 1.54, 95% CI 0.41 to 5.74; 3 studies; 1197 participants; very low‐certainty evidence); or heparin‐induced thrombocytopaenia (RR 0.21, 95% CI 0.01 to 4.27; 3 studies; 443 participants; very low‐certainty evidence). The main reasons for downgrading the certainty of evidence for the primary and secondary outcomes were unclear allocation concealment, suspicion of publication bias, imprecision and inconsistency. Given the low‐certainty evidence, we are uncertain whether intermittent locking with heparin results in fewer central venous catheter occlusions than intermittent locking with normal saline in adults. Low‐certainty evidence suggests that heparin may have little or no effect on catheter patency duration. Although we found no evidence of differences in safety (CVC‐related bloodstream infections, mortality, or haemorrhage), the combined studies were not powered to detect rare adverse events such as heparin‐induced thrombocytopaenia. Further research conducted over longer periods would reduce the current uncertainties. Key message We did not find clear evidence of a difference between heparin and normal saline solution (sterile solution of salt in water) in preventing central venous catheter blockages (occlusions), or in the length of time catheters remained unblocked, or in the number of side effects such as infections, death, bleeding, etc. Further well‐designed, large‐scale studies are required to reduce uncertainties. Why is this question important? Central venous catheters are tubes (also called 'lines') that must be temporarily placed into the veins of patients whose veins need to be accessed regularly for medical reasons. These are inserted into the great vessels leading to the heart. While not in use, a fluid is injected into the catheter until it is next used to avoid blood cl -Abstract Truncated-

Pediatric Central Venous Access Device Lock Solutions: A Network Meta-analysis

Comparative Efficacy and Safety of Lock Solutions for the Prevention of Catheter-Related Complications Including Infectious and Bleeding Events in Adult Haemodialysis Patients: a Systematic Review and Network Meta-Analysis

Comparative Efficacy and Safety of Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Network Meta-Analysis

Catheter Lock Solutions for Reducing Catheter-Related Bloodstream Infections in Paediatric Patients: a Network Meta-Analysis

Locking solutions for prevention of central venous access device complications in the adult critical care population: A systematic review

Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer

Systematic Review of the Safety and Efficacy of Central Vascular Access Device Securement

Central venous access device adverse events in pediatric patients with cancer: a systematic review and meta-analysis

Risk Factors for Central Venous Access Device-Related Thrombosis in Hospitalized Children: A Systematic Review and Meta-Analysis

Use of 4% tetrasodium EDTA (KiteLock™) to prevent central venous catheter-related bloodstream infections in pediatric hemodialysis patients

Administration of 4% tetrasodium EDTA lock solution and central venous catheter complications in high‐risk pediatric patients with intestinal failure: A retrospective cohort study

The effectiveness of dressings and securement devices to prevent central venous catheter-associated complications: A systematic review and meta-analysis

Comparing Complication Rates of Midline Catheter vs Peripherally Inserted Central Catheter. A Systematic Review and Meta-analysis

Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial)

Low-dose Versus High-Dose Heparin Locks for Hemodialysis Catheters: a Systematic Review and Meta-Analysis

Novel Peripheral Intravenous Catheter Securement for Children and Catheter Failure Reduction: A Randomized Clinical Trial

Successful Prevention of Cuffed Hemodialysis Catheter-Related Infection Using an Antibiotic Lock Technique by Strictly Catheter-Restricted Antibiotic Lock Solution Method.

Efficacy of 4% tetrasodium ethylenediaminetetraacetic acid (T-EDTA) catheter lock solution in home parenteral nutrition patients: A quality improvement evaluation

Antibiotic lock solutions as adjunct therapy for catheter-related blood stream infections in pediatric hemodialysis patients

Advancing Evidence-Based Peripheral Intravenous Catheter Securement